Document is current
Any future updates will be listed below
-
Authors
Elieh-Ali-Komi, Daniel https://orcid.org/0000-0003-0546-5280
Bot, Ilze https://orcid.org/0000-0002-1242-1959
Rodríguez-González, Mónica https://orcid.org/0000-0002-9149-1137
Maurer, Marcus https://orcid.org/0000-0002-4121-481X
-
Funding
Funding for this research was provided by:
Dutch Heart Foundation (2019T067)
Charité - Universitätsmedizin Berlin
- License Information
-
More Information
Article History
Accepted: 19 January 2024
First Online: 30 January 2024
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: No informed consent was required to prepare the manuscript.
: Marcus Maurer is or recently was a speaker and/or advisor for and/or has received research funding from Allakos, Amgen, Aquestive, Aralez, AstraZeneca, Astria, Bayer, BioCryst, Blueprint, Celldex, Celltrion, Centogene, CSL Behring, Evommune, GSK, Ipsen, KalVista, Kyowa Kirin, Leo Pharma, Lilly, Menarini, Mitsubishi Tanabe Pharma, Moxie, Noucor, Novartis, Pharvaris, Sanofi/Regeneron, Septerna, Takeda, Teva, Third Harmonic Bio, Valenza Bio, Yuhan Corporation, and Zurabio. I.B. is an established investigator of the Dutch Heart Foundation (2019T067). The other authors declare that they have no conflict of interest.
